Creators of Mysterious Ad Blitz Influencing Anti-Surprise Billing Law Comes to Light

Picture sitting in your living room watching the evening news when the broadcast goes to break and cuts to a scene of a badly injured 16-year-old girl en route to the hospital via ambulance. The actors appear professional and the camerawork superb—almost like something you’d see on a network TV drama.

Surprise Billing: Arbitration Will Raise Your Premiums

As we continue our national discussion of how to address surprise billing, one idea that keeps coming up – and needs to stop – is arbitration. 

Insys Therapeutics Admits to Bribing Doctors to Write Opioid Prescriptions

Imagine for a second that you knew a product you were manufacturing was killing people in droves. Now think about being the type of company who would bribe a doctor to prescribe that product to their patients. It’s inconceivable. It’s reprehensible. It’s exactly what Insys Therapeutics was doing.

SB 432 – Lots of Treats for Pharmacists – and Bad News for Consumers

Anti-Pharmacy Benefit Manager (PBM) legislation has been pushed by big pharma this year, and for an obvious reason – their bottom line. HB 534, the “Pharmacy Benefits Manager Licensure Act” would have massively hampered the ability for your insurer’s PBM to negotiate the price of drugs.  This would have resulted in higher costs of medication, which in turn would mean higher health insurance premiums. It was the kind of bill that would have hit North Carolina’s families and businesses - already struggling with rising health care costs - hard.

Podcast: Senator Joyce Krawiec Talks to Us About Why CON Laws are Bad for NC

When asked who might be against the removal of outdated and restrictive Certificate of Need (CON) laws, Senator Joyce Krawiec lets out a laugh. It’s not a nervous laugh, but one that’s hearty and genuine. More than anything, it’s a gesture of astonishment and bewilderment. So, just who would be against ridding the state of guidelines that limit new healthcare providers from entering the market?

Study Finds Prescription Drugs Double in Price Every 7 to 8 Years

It’s an obvious exaggeration to say that drug prices will have increased again by the time you finish reading this sentence, but it’s probably not that far off. A new study published in the Journal of the American Medical Association (JAMA) Network Open says that the cost of brand-name prescription drugs doubled every 7 to 8 years.